This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Annaly in Play, Crexus Prices Secondary Offering

(Annaly Capital (NLY - Get Report), Crexus (CXS) report updated with recent broker action on Annaly Capital.)
NEW YORK ( TheStreet) -- Crexus Investment (CXS), in which Annaly Capital Management (NLY - Get Report) is a 25% owner, rejected an acquisition bid from Starwood Property Trust (STWD - Get Report) and priced a secondary offering at a steep discount.

Crexus shares had surged nearly 14% at midday Monday when Starwood Property made an unconditional offer to acquire all of the outstanding shares of Crexus Investment for $14.00 per share. That offer represented a 20% premium to Crexus' trading price earlier in the day, ahead of the offer.

Starwood's offer was contingent on Crexus abandoning its plans for a secondary offering. The offering was announced a week earlier as Crexus looked to acquire a commercial real estate mortgage loan portfolio from Barclays Capital (BCS).

But Crexus rejected Starwood's bid and then late Monday Crexus announced it had priced the underwritten public offering of 50 million shares at $11.50 per share, hoping to raise gross proceeds of around $575 million. Underwriters were granted the option to purchase up to an additional 7.5 million shares to cover over-allotments.

Concurrent with the offering, Annaly Capital, the parent company of Crexus' external manager, Fixed Income Discount Advisory, will acquire 5 million shares of Crexus in a private placement at the same price per share.

Both offerings are expected to close on or around April 1.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BCS $16.56 0.18%
NLY $10.35 0.19%
STWD $23.90 -0.02%
AAPL $130.68 -0.83%
FB $79.13 -1.30%

Markets

DOW 18,040.14 -85.98 -0.47%
S&P 500 2,110.29 -10.50 -0.50%
NASDAQ 5,074.3440 -23.6320 -0.46%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs